New CDC data shows a significant rise in autism prevalence and a notable shift - for the first time, it is more common in minority children. Get the key statistics here!
The Centers for Disease Control and Prevention (CDC) is a key source of information and research on autism spectrum disorder (ASD). It serves as a leading national authority on ASD, dedicated to monitoring its impact, advancing research, promoting early intervention, and providing essential information to improve the lives of individuals with ASD and their families.
Tracking the Prevalence of Autism
The Centers for Disease Control and Prevention (CDC) tracking the prevalence of autism is crucial for several interconnected reasons that have significant implications for public health, policy, research, and the well-being of individuals with Autism Spectrum Disorder (ASD) and their families.
- Comparing Prevalence Across Different Populations: Monitoring allows for examination of prevalence rates across various demographic groups, for instance, by race, ethnicity, sex, socioeconomic status, geographic location. This can reveal disparities and help identify populations that may be at higher risk or underserved.
- Informing Policy & Resource Allocation: Accurate prevalence data is essential for policymakers to make informed decisions about allocating resources and funds for research, early intervention programs, educational services, healthcare, and support for individuals with ASD and their families. Knowing the number of affected individuals helps estimate the necessary financial investment.
- Planning for Service Needs: Understanding the prevalence helps communities and states’ plans for the increasing demand for diagnostic services, therapies (e.g., speech-oral placement therapy, early occupational therapy, ABA therapy), specialized education, and adult support services.
- Raising Awareness & Reducing Stigma: Publishing prevalence data helps raise awareness about ASD as a significant public health issue, which can lead to greater understanding and acceptance in communities. Moreover, increased awareness and understanding can contribute to reducing the stigma associated with ASD, encouraging early diagnosis and support-seeking behaviors.
What Does the Latest Data Reveal?
- Increased Overall Prevalence: The most recent data from ADDM Network in 2022 indicates that about 1 in 31 (3.2 %) children aged 8 years were identified with ASD. This is a significant increase from the 2020 data, which reported a prevalence of 1 % in 36 (2.7%) among 8 year olds across 11 sites.
- Race & Ethnicity: For the first time, the data indicates that ASD is more prevalent among minority children than white children. Specifically, the prevalence was highest among: American Indian or Alaska Native children (3.8 %), Asian or Pacific Islander Children (3.8%), Black Children (3.7%), Hispanic Children (3.3%). The prevalence among white children was 2.7%.
- Gender: ASD continues to be more common among boys than girls, with boys being 3.4 times more likely to be diagnosed with autism than girls among 8 year olds.
- Socioeconomic Status: At all of the surveyed sites, no association was observed between ASD prevalence and neighborhood median household income. However, at five sites, higher ASD prevalence was associated with lower neighborhood median household income.
- Age of Diagnosis: The median age of diagnosis was 47 months (about 4 years). Encouragingly, children born in 2018 were 1.7 times more likely to be identified with autism by age 4 than children born in 2014, suggesting that early identification efforts are having a positive impact.
- Identification Source: Schools remain a critical point of identification, with 67.3% of children with autism being identified through special education eligibility. However, nearly 18% were identified based on this criterion alone, without a documented medical diagnosis, highlighting potential gaps in evaluation.
Overall, the latest CDC data highlights a continued increase in autism prevalence, along with significant shifts in demographic patterns, particularly regarding race and ethnicity. While there is progress in earlier diagnosis, disparities persist, and a substantial proportion of children with autism also have co-occurring intellectual disabilities.
This data underscores the ongoing need for research, accessible diagnostic services, early intervention, therapies like speech-oral placement, early occupational therapy, ABA therapy and support for individuals with ASD and their families.
Connect with Compassionate Behavior Care to explore our range of developmental therapies and professional courses designed to support growth and transformation.
+971554960984 | info@compassionatebehaviorcare.com